Detalhe da pesquisa
1.
Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma.
Blood
; 2024 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657242
2.
High efficacy of CD19 CAR T-cells in patients with transformed Waldenström macroglobulinemia.
Blood
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669635
3.
Obinutuzumab versus Rituximab in transplant-eligible Mantle cell lymphoma patients.
Blood
; 2024 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669626
4.
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Blood
; 142(10): 865-877, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300386
5.
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
Lancet
; 401(10392): 1941-1950, 2023 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105210
6.
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.
Blood
; 140(24): 2584-2593, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36122385
7.
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.
Blood
; 139(15): 2338-2346, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936697
8.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385243
9.
CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.
Am J Hematol
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586986
10.
Obinutuzumab-induced acute thrombocytopenia: Report of two cases and review of literature.
Br J Haematol
; 202(1): 168-172, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37143375
11.
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
N Engl J Med
; 382(14): 1331-1342, 2020 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242358
12.
Emerging and Evolving Concepts in Cancer Immunotherapy Imaging.
Radiology
; 306(1): 32-46, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36472538
13.
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Haematologica
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031755
14.
Dissemination patterns of Hodgkin lymphoma using a probability network model based on [18F]-FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 50(5): 1414-1422, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36522437
15.
Clinical features and outcomes of patients admitted to the ICU for Cyclophosphamide-associated cardiac toxicity: a retrospective cohort.
Support Care Cancer
; 31(8): 474, 2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37462731
16.
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Lancet
; 398(10299): 491-502, 2021 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097852
17.
Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.
Hematol Oncol
; 40(5): 976-986, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35789106
18.
Interpretation of 2-[18F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors.
Eur Radiol
; 32(9): 6536-6544, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344061
19.
Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre study.
Acta Oncol
; 61(11): 1339-1346, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239950
20.
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Br J Haematol
; 195(3): 388-398, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590303